Navigation Links
VIVUS Announces FDA Acceptance of Avanafil New Drug Application for Treatment of Erectile Dysfunction
Date:9/1/2011

MOUNTAIN VIEW, Calif., Sept. 1, 2011 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's new drug application (NDA) for its investigational drug candidate, avanafil, for the treatment of erectile dysfunction (ED). The target date for the FDA to complete its review of the avanafil NDA is April 29, 2012. In previously announced results from the pivotal phase 3 trials, patients treated with avanafil achieved significant improvement in erectile function compared to placebo. The avanafil development program included over 1,350 patients and avanafil was shown to be well tolerated and effective in treating patients with general ED and diabetics with ED. The long-term safety study also confirmed the results observed in the phase 3 studies.

"We are pleased with FDA's acceptance of our NDA. If approved, avanafil could be a valuable treatment alternative for the 18 million men in the United States that suffer from ED," stated Peter Y. Tam, president of VIVUS.

About AvanafilAvanafil is an investigational oral medication being developed for the treatment of erectile dysfunction.  Avanafil is a highly selective phosphodiesterase type 5 (PDE5) inhibitor licensed from Mitsubishi Tanabe Pharma Corporation. VIVUS owns worldwide development and commercial rights to avanafil for the treatment of sexual dysfunction, with the exception of certain Asian Pacific Rim countries.

About VIVUS VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company's lead investigational product in clinical development, QNEXA®, has completed phase 3 clinical trials for the treatment of obesity and is currently being considered for approval by US and EU regulators. VIVUS received a Complete Response Letter, or CRL,
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. VIVUS Announces $45.8 Million Registered Direct Offering of Common Stock
2. VIVUS Reports Second Quarter and First Six Months 2011 Financial Results
3. VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results
4. VIVUS to Present at Three Upcoming Investor Conferences in March
5. VIVUS Provides Regulatory Update on QNEXA NDA
6. VIVUS to Present at the 2011 JP Morgan Healthcare Conference
7. VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA®
8. VIVUS to Present at Two Upcoming Investor Conferences
9. VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results
10. FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA®
11. VIVUS Announces Sale of MUSE Assets to Meda
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... CHAPEL HILL, N.C. , Aug. 29, 2014 /PRNewswire/ ... Opinion Leaders (KOLs) can be the difference between a ... struggle to effectively map and stratify KOL targets – ... to build the type of strong relationships upon which ... recent research, savvy pharma companies have identified internal inconsistencies ...
(Date:8/29/2014)... Ore. , Aug. 29, 2014 /PRNewswire-iReach/ -- ... Accessory (Axilla) Strap for the SAM Junctional Tourniquet.  ... SAM Medical Products announced today ... voluntary recall to address a potential issue with ... used for the Axilla application of the SAM ...
(Date:8/29/2014)... MARLBOROUGH, Mass. , Aug. 29, 2014 /PRNewswire/ ... ) prospective, multinational study on stent removability and ... strictures has been published in the August issue ... The multinational study 1 is being conducted ... removal of fully covered self-expanding metal stents (FCSEMS) ...
Breaking Medicine Technology:Implementing a Strategic Thought Leader Management & Engagement System 2SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4
... COLUMBUS and ZANESVILLE, Ohio , May ... www.huntington.com ) has created a unique funding model to finance ... installation at one of the region,s largest health care providers, ... equipment finance deal will install a clinical information system ...
... YORK , May 12 Reportlinker.com announces that a new market research report is ... Ophthalmic Therapeutic Drugs: Technologies and Global Markets ... http://www.reportlinker.com/p0196569/Ophthalmic-Therapeutic-Drugs-Technologies-and-Global-Markets.html , , ... , , ...
Cached Medicine Technology:Huntington Financing Package Supports Major Regional Medical Center Electronic Medical Records Project 2Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 2Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 3Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 4Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 5Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 6Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 7Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 8Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 9Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 10Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 11Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 12Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 13Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 14Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 15Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 16Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 17Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 18Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 19Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 20Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 21Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 22Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 23Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 24Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets 25
(Date:8/31/2014)... 31, 2014 Just in time for Washington’s ... only wild, sustainable Alaska Salmon, award winning chowder ... Duke's Green Lake location , Sunday, September 28, 2014 ... sample several ethnic salmon BBQ culinary delights. Live music will ... from Hawaii, Puerto Rico and Mexico will be featured. ...
(Date:8/31/2014)... Recently, BambooIndustry.com, one of the most popular suppliers of ... of bamboo veneers . Additionally, it has deiced offer ... high quality products. The promotion will last from today until ... its top quality veneers are hot in the global market. ... bamboo veneers. All these items are made according to our ...
(Date:8/31/2014)... Mesa, AZ (PRWEB) August 31, 2014 ... in Mesa, Arizona, prescribes sublingual immunotherapy to help his ... includes tree nut allergies. Dr. Agren said that it ... nut-based foods and, in many cases, restored peace of ... can lead to a host of symptoms, including rashes, ...
(Date:8/31/2014)... With years of hard work, Delta has now ... machines. Recently, the company has updated its wheel loader ... loaders. All these items are guaranteed to be great. Additionally, ... , It is true that all items in Delta’s ... machine specialists. The firm is making full efforts to help ...
(Date:8/31/2014)... (PRWEB) August 31, 2014 1Heart Caregiver ... Clarito and brain fitness expert Tee Barr conducted a ... Ventura City. Activities Director Virginia Ayala and Social Services ... and patients attend this brain fitness session. , Research ... and slowing down the development of dementia and memory ...
Breaking Medicine News(10 mins):Health News:Seattle Seafood Restaurant Duke's Chowder House on Green Lake Will Celebrate The Long Anticipated Indian Summer With First Annual Sizzling BBQ Salmon Tasting Event. 2Health News:High Quality Bamboo Veneers from Bambooindustry.com Receive International Attention 2Health News:Family Allergy Clinic Announces Q4 2014 Release of Oral Drops for Tree Nut Allergies 2Health News:Family Allergy Clinic Announces Q4 2014 Release of Oral Drops for Tree Nut Allergies 3Health News:Delta Updates Its Wheel Loader Assortment With A Lot Of Cheap Used Cat 966 Loaders 2Health News:1Heart Caregiver Services Director Randy Neil Clarito Brings Brain Fitness Education to Victoria Care Center Ventura 2Health News:1Heart Caregiver Services Director Randy Neil Clarito Brings Brain Fitness Education to Victoria Care Center Ventura 3Health News:1Heart Caregiver Services Director Randy Neil Clarito Brings Brain Fitness Education to Victoria Care Center Ventura 4
... University of Wisconsin-Madison Center of Excellence in Cancer Communications Research ... Breast cancer patients who pray in online support groups can ... many cancer patients pray in online support groups to help ... we are aware of that examines the psychological effects of ...
... to alleviate symptoms of early-stage Parkinson's disease, and may ... manage the brain disorder,// researchers said., ,A neupro ... used to study its effects on 277 people in ... patch is designed to convey a drug called ...
... a customised personal digital assistant (PDA) to dramatically ... said Thursday. ,Instead of fumbling with ... speech impairments express their needs in such everyday ... attention from an archive of commonly-used phrases and ...
... regarded as a psychological disorder. Dr Sabine Nissan from Karolinska ... Sweden. ,The researchers found out that a third ... suffer from other metabolic disorders. The study points of that ... imbalance. The patients may often be overeating due to hormonal ...
... suggests a link between a particular gene named ApoE-4 ... Neurobiology of Aging, published the results of the research. ... in causing Alzheimer’s disease. ,This research now is ... the possibility that occurrence of herpes infection earlier in ...
... may have a greater risk of getting prostate cancer, according ... families of men diagnosed with prostate cancer with other men ... cancer were related. ,The Journal of the National ... the factors responsible for prostate cancer and having more daughters ...
Cached Medicine News:Health News:Online Prayers Helps Cancer Patients 2Health News:Excessive Male Hormones can Cause Bulimia in Women 2Health News:Herpes Simplex and Alzheimer’s Disease Linked to Single Gen 2Health News:Herpes Simplex and Alzheimer’s Disease Linked to Single Gen 3Health News:Herpes Simplex and Alzheimer’s Disease Linked to Single Gen 4Health News:Gender Of Children May Be Linked To Risk Of Prostate Cancer 2
... Central Blood Pressure/Pulse Wave Velocity System is an ... system enables the measurement of the velocity of ... The velocity of the pressure wave along the ... artery. This system is most commonly used to ...
Used to remove wrinkles from sections and for reorientating embedded tissue....
Liquichek Blood Gas Plus CO-Oximeter Control (Radiometer) is a combination control for use in monitoring the performance of blood gas, ion-selective electrode, biosensor and CO-Oximeter (Radiometer) ...
Liquichek Blood Gas Plus E Control is an aqueous product used to monitor the measurement of pH, pCO2, pO2 and electrolytes. Available in four levels....
Medicine Products: